Journal article
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study
- Abstract:
- BACKGROUND: Blood neurofilament light chain (NfL) is increasingly considered as a key trial biomarker in genetic frontotemporal dementia (gFTD). We aimed to facilitate the use of NfL in gFTD multicentre trials by testing its (1) reliability across labs; (2) reliability to stratify gFTD disease stages; (3) comparability between blood matrices and (4) stability across recruiting sites. METHODS: Comparative analysis of blood NfL levels in a large gFTD cohort (GENFI) for (1)-(4), with n=344 samples (n=148 presymptomatic, n=11 converter, n=46 symptomatic subjects, with mutations in C9orf72, GRN or MAPT; and n=139 within-family controls), each measured in three different international labs by Simoa HD-1 analyzer. RESULTS: NfL revealed an excellent consistency (intraclass correlation coefficient (ICC) 0.964) and high reliability across the three labs (maximal bias (pg/mL) in Bland-Altman analysis: 1.12±1.20). High concordance of NfL across laboratories was moreover reflected by high areas under the curve for discriminating conversion stage against the (non-converting) presymptomatic stage across all three labs. Serum and plasma NfL were largely comparable (ICC 0.967). The robustness of NfL across 13 recruiting sites was demonstrated by a linear mixed effect model. CONCLUSIONS: Our results underline the suitability of blood NfL in gFTD multicentre trials, including cross-lab reliable stratification of the highly trial-relevant conversion stage, matrix comparability and cross-site robustness
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 872.5KB, Terms of use)
-
- Publisher copy:
- 10.1136/jnnp-2023-332464
- Publication website:
- https://discovery.ucl.ac.uk/10186136/1/jnnp-2023-332464.full.pdf
Authors
+ Alzheimer's Association
More from this funder
- Funder identifier:
- 10.13039/100000957
- Grant:
- ADSF-21-831376-C
- ADSF-21-831377-C
- ADSF-21-831381-C
+ National Institute for Health Research Cambridge Biomedical Research Centre
More from this funder
- Funder identifier:
- 10.13039/501100018956
- Grant:
- BRC-1215-20014
+ Erling-Persson Family Foundation
More from this funder
- Funder identifier:
- 10.13039/100007436
- Grant:
- N/A
- Publisher:
- BMJ Publishing Group
- Journal:
- Journal of Neurology, Neurosurgery and Psychiatry More from this journal
- Volume:
- 95
- Issue:
- 9
- Pages:
- 822-828
- Publication date:
- 2024-01-19
- Acceptance date:
- 2023-12-31
- DOI:
- EISSN:
-
1468-330X
- ISSN:
-
0022-3050
- Language:
-
English
- Keywords:
- Pubs id:
-
1700353
- Local pid:
-
pubs:1700353
- Source identifiers:
-
W4391109464
- Deposit date:
-
2026-06-08
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2024
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record